Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ

Published:2018-07 Issue: Volume:103 Page:272-283
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Han Mei,Gao Hui,Ju Ping,Gao Ming-quan,Yuan Yin-ping,Chen Xue-hong,Liu Kai-li,Han Yan-tao,Han Zhi-wu

Funder

Qingdao University

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference52 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J. Clin.,2016

2. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration;Zampino;Ann. Hepatol.,2015

3. Novel sequence determinants in peroxisome proliferator signaling;Palmer;J. Biol. Chem.,1995

4. Peroxisome-proliferator-activated receptors and cancers: complex stories;Michalik;Nat. Rev. Cancer.,2004

5. PPARγ is an E3 ligase that induces the degradation of NFκB/p65;Hou;Nat. Commun.,2012

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway;BMC Cancer;2024-09-02

2. Dual function of activated PPARγ by ligands on tumor growth and immunotherapy;Medical Oncology;2024-04-15

3. Roles of peroxisome proliferator‐activated receptors in hepatocellular carcinoma;Journal of Cellular and Molecular Medicine;2023-11-20

4. Hispidulin: a promising anticancer agent and mechanistic breakthrough for targeted cancer therapy;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-08-18

5. Hispidulinin Sağlıklı Hücre Hatlarında Sitotoksik, Apoptotik ve Nekrotik Etkilerinin Değerlendirilmesi;Black Sea Journal of Engineering and Science;2023-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3